Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Clinical trial NCT05855200 · RECRUITING
Trial details
- NCT number
- NCT05855200
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2029-03-19
- Enrollment
- 892
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.